(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are BioCardia, Tilray, and Moderna.

Rank Financial Asset Price Change Updated (EST)
1 BioCardia (BCDAW) 1.05 28.05% 2022-01-13 20:23:12
2 Tilray (TLRY) 7.29 13.55% 2022-01-14 03:32:58
3 Moderna (MRNA) 233.70 9.28% 2022-01-14 03:32:00
4 Cemtrex (CETXP) 1.96 8.89% 2022-01-14 07:10:06
5 Dogness (DOGZ) 3.74 8.72% 2022-01-14 15:48:14
6 Coupons.com (COUP) 147.66 7.3% 2022-01-13 20:32:17
7 Zscaler (ZS) 275.65 5.4% 2022-01-14 03:33:42
8 Conifer Holdings (CNFR) 2.47 5.11% 2022-01-14 10:44:12
9 Bellerophon Therapeutics (BLPH) 3.24 4.85% 2022-01-13 23:02:29
10 Berkeley Lights (BLI) 10.03 4.26% 2022-01-13 22:42:13

The three most active and biggest losers today are Daseke, Brilliant Acquisition Corporation, and CureVac N.V..

Rank Financial Asset Price Change Updated (EST)
1 Daseke (DSKEW) 0.05 -26.03% 2022-01-14 16:23:13
2 Brilliant Acquisition Corporation (BRLIW) 0.16 -15.26% 2022-01-14 00:09:47
3 CureVac N.V. (CVAC) 23.22 -14.1% 2022-01-14 13:15:06
4 Avinger (AVGR) 0.31 -12.15% 2022-01-13 19:12:06
5 Black Diamond Therapeutics (BDTX) 4.50 -11.76% 2022-01-13 21:07:20
6 BeyondSpring (BYSI) 3.80 -10.59% 2022-01-14 04:17:07
7 BiondVax Pharmaceuticals Ltd. (BVXV) 1.82 -9.45% 2022-01-14 03:48:12
8 American Virtual Cloud Technologies (AVCTW) 0.20 -9.14% 2022-01-13 19:10:06
9 Trip.com (TCOM) 23.23 -7.15% 2022-01-14 03:32:53
10 Crexendo (CXDO) 4.42 -6.55% 2022-01-14 13:42:14

Most Active Winners today

1. BioCardia (BCDAW) – 28.05%

NASDAQ Composite ended the session with BioCardia rising 28.05% to $1.05 on Friday while NASDAQ Composite jumped 0.05% to $14,942.83.

BioCardia’s last close was $1.05, 0% under its 52-week high of $1.05.

BioCardia’s Stock Yearly Top and Bottom Value

BioCardia’s stock is valued at $1.05 at 16:32 EST, under its 52-week low of $1.05.

More news about BioCardia.

2. Tilray (TLRY) – 13.55%

NASDAQ Composite ended the session with Tilray jumping 13.55% to $7.29 on Friday, after four sequential sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Tilray is 106000000 which is 323.43% above its average volume of 25033300.

Tilray’s last close was $6.87, 82.17% under its 52-week high of $38.53.

News about Tilray today

  • Tilray rally fades as investor doubts about pot stocks prevail. According to today’s article on Bloomberg Quint, "Canadian cannabis titan Tilray Inc. fell for a third straight day, surrendering much of a rally posted earlier this week after earnings that were buoyed by acquisitions and a rebranding — moves aimed at strengthening its global reach in the face of stiff competition at home.", "The longer legalization takes, the more the U.S. cannabis companies will grow and consolidate the industry," said Pablo Zuanic, an analyst at Cantor Fitzgerald LP, who gives both Tilray and Canopy neutral ratings. "

The company’s growth estimates for the present quarter and the next is a negative 250% and a negative 200%, respectively.

Tilray’s Revenue

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 513.08M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tilray’s stock is considered to be overbought (>=80).

Tilray’s Stock Yearly Top and Bottom Value

Tilray’s stock is valued at $7.29 at 16:32 EST, below its 52-week low of $7.93.

Tilray’s Moving Average

Tilray’s value is way below its 50-day moving average of $10.73 and way below its 200-day moving average of $14.96.

More news about Tilray.

3. Moderna (MRNA) – 9.28%

NASDAQ Composite ended the session with Moderna rising 9.28% to $233.70 on Friday, following the last session’s downward trend. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Moderna is 17191500 which is 46.44% above its average volume of 11739100.

Moderna’s last close was $210.17, 57.75% below its 52-week high of $497.49.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the ongoing quarter and 1202.8% for the next. The company’s growth estimates for the current quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be overbought (>=80).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $233.70 at 16:32 EST, way below its 52-week high of $497.49 and way above its 52-week low of $102.66.

Moderna’s Moving Average

Moderna’s worth is way below its 50-day moving average of $298.96 and way under its 200-day moving average of $267.83.

Previous days news about Moderna

  • Moderna inc (mrna) stock price and forecast: Moderna works on omicron booster. According to FXStreet on Tuesday, 11 January, "However, as more and more evidence mounted that Omicron appears less severe, Moderna has resumed the downtrend with the occasional spike as witnessed yesterday."

More news about Moderna.

4. Cemtrex (CETXP) – 8.89%

NASDAQ Composite ended the session with Cemtrex jumping 8.89% to $1.96 on Friday, after two successive sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Cemtrex is 10 which is 98.9% below its average volume of 914.

Cemtrex’s last close was $1.80, 44.57% under its 52-week high of $3.25.

Cemtrex’s Revenue

Year-on-year quarterly revenue growth grew by 22.3%, now sitting on 39.17M for the twelve trailing months.

Cemtrex’s Stock Yearly Top and Bottom Value

Cemtrex’s stock is valued at $1.96 at 16:32 EST, way under its 52-week high of $3.25 and way higher than its 52-week low of $1.44.

Cemtrex’s Moving Average

Cemtrex’s value is under its 50-day moving average of $2.10 and under its 200-day moving average of $2.13.

More news about Cemtrex.

5. Dogness (DOGZ) – 8.72%

NASDAQ Composite ended the session with Dogness jumping 8.72% to $3.74 on Friday while NASDAQ Composite rose 0.05% to $14,942.83.

Volume

Today’s last reported volume for Dogness is 4376270 which is 87.46% above its average volume of 2334400.

Dogness’s last close was $3.04, 66.15% below its 52-week high of $8.98.

Dogness’s Revenue

Year-on-year quarterly revenue growth grew by 56.9%, now sitting on 24.32M for the twelve trailing months.

Dogness’s Stock Yearly Top and Bottom Value

Dogness’s stock is valued at $3.74 at 16:32 EST, way below its 52-week high of $8.98 and way above its 52-week low of $1.30.

Dogness’s Moving Average

Dogness’s worth is way below its 50-day moving average of $5.25 and way above its 200-day moving average of $2.98.

More news about Dogness.

6. Coupons.com (COUP) – 7.3%

NASDAQ Composite ended the session with Coupons.com jumping 7.3% to $147.66 on Friday while NASDAQ Composite jumped 0.05% to $14,942.83.

Volume

Today’s last reported volume for Coupons.com is 2275850 which is 34.77% above its average volume of 1688590.

Coupons.com’s last close was $141.44, 62.49% under its 52-week high of $377.04.

The company’s growth estimates for the present quarter and the next is a negative 88.9% and a negative 135.3%, respectively.

Coupons.com’s Revenue

Year-on-year quarterly revenue growth grew by 42.3%, now sitting on 642.68M for the twelve trailing months.

Coupons.com’s Stock Yearly Top and Bottom Value

Coupons.com’s stock is valued at $147.66 at 16:32 EST, under its 52-week low of $154.22.

Coupons.com’s Moving Average

Coupons.com’s value is way under its 50-day moving average of $219.20 and way under its 200-day moving average of $237.78.

More news about Coupons.com.

7. Zscaler (ZS) – 5.4%

NASDAQ Composite ended the session with Zscaler jumping 5.4% to $275.65 on Friday while NASDAQ Composite rose 0.05% to $14,942.83.

Volume

Today’s last reported volume for Zscaler is 3971900 which is 74% above its average volume of 2282630.

Zscaler’s last close was $250.47, 33.41% below its 52-week high of $376.11.

The company’s growth estimates for the current quarter is a negative 14.3% and positive 20% for the next.

Zscaler’s Revenue

Year-on-year quarterly revenue growth grew by 59.6%, now sitting on 601.91M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zscaler’s stock is considered to be overbought (>=80).

Zscaler’s Stock Yearly Top and Bottom Value

Zscaler’s stock is valued at $275.65 at 16:32 EST, way below its 52-week high of $376.11 and way above its 52-week low of $157.03.

Zscaler’s Moving Average

Zscaler’s worth is way below its 50-day moving average of $315.18 and way above its 200-day moving average of $239.83.

More news about Zscaler.

8. Conifer Holdings (CNFR) – 5.11%

NASDAQ Composite ended the session with Conifer Holdings jumping 5.11% to $2.47 on Friday, following the last session’s upward trend. NASDAQ Composite rose 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Conifer Holdings is 8826 which is 59.68% below its average volume of 21895.

Conifer Holdings’s last close was $2.46, 48.96% under its 52-week high of $4.82.

Conifer Holdings’s Sales

Conifer Holdings’s sales growth is 14.7% for the present quarter and 27.4% for the next. The company’s growth estimates for the current quarter and the next is 57.7% and 86.1%, respectively.

Conifer Holdings’s Revenue

Year-on-year quarterly revenue growth declined by 10%, now sitting on 106.78M for the twelve trailing months.

Conifer Holdings’s Stock Yearly Top and Bottom Value

Conifer Holdings’s stock is valued at $2.47 at 16:32 EST, way under its 52-week high of $4.82 and way above its 52-week low of $2.10.

Conifer Holdings’s Moving Average

Conifer Holdings’s value is above its 50-day moving average of $2.42 and way below its 200-day moving average of $2.85.

More news about Conifer Holdings.

9. Bellerophon Therapeutics (BLPH) – 4.85%

NASDAQ Composite ended the session with Bellerophon Therapeutics rising 4.85% to $3.24 on Friday, after three successive sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Bellerophon Therapeutics is 120361 which is 86.66% below its average volume of 902519.

Bellerophon Therapeutics’s last close was $2.93, 68.1% under its 52-week high of $9.19.

The company’s growth estimates for the current quarter is 25.6% and a drop 8.6% for the next.

Bellerophon Therapeutics’s Stock Yearly Top and Bottom Value

Bellerophon Therapeutics’s stock is valued at $3.24 at 16:32 EST, way below its 52-week high of $9.19 and way higher than its 52-week low of $2.34.

Bellerophon Therapeutics’s Moving Average

Bellerophon Therapeutics’s worth is higher than its 50-day moving average of $3.07 and way under its 200-day moving average of $3.96.

More news about Bellerophon Therapeutics.

10. Berkeley Lights (BLI) – 4.26%

NASDAQ Composite ended the session with Berkeley Lights jumping 4.26% to $10.03 on Friday, after two consecutive sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Berkeley Lights is 3997820 which is 209.69% above its average volume of 1290900.

Berkeley Lights’s last close was $9.51, 89.44% below its 52-week high of $90.09.

Berkeley Lights’s Sales

Berkeley Lights’s sales growth is 30.3% for the ongoing quarter and 35.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 31.6% and a negative 20.8%, respectively.

Berkeley Lights’s Revenue

Year-on-year quarterly revenue growth grew by 33.6%, now sitting on 83.95M for the twelve trailing months.

Berkeley Lights’s Stock Yearly Top and Bottom Value

Berkeley Lights’s stock is valued at $10.03 at 16:32 EST, way under its 52-week high of $90.09 and way above its 52-week low of $9.05.

Berkeley Lights’s Moving Average

Berkeley Lights’s worth is way below its 50-day moving average of $19.81 and way below its 200-day moving average of $34.45.

Previous days news about Berkeley Lights

  • Berkeley lights shareholder alert BY former Louisiana attorney general: KAHN swick & foti, LLC reminds investors WITH losses IN excess OF $100,000 of lead plaintiff deadline in class action lawsuit against berkeley lights, inc. – BLI. According to Benzinga on Thursday, 13 January, "If you purchased shares of Berkeley Lights and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-bli/ to learn more. ", "On this news, shares of Berkeley Lights plummeted nearly 30% over two trading days to close at $23.53 on September 16, 2021, on abnormally high trading volume."
  • Shareholder alert: pomerantz law firm investigates claims on behalf of investors of berkeley lights, inc. – BLI. According to Benzinga on Thursday, 13 January, "On or around July 17, 2020, Berkeley Lights conducted its initial public offering ("IPO"), selling 8.1 million shares priced at $22.00 per share. ", "Then, on September 15, 2021, the analyst Scorpion Capital ("Scorpion") published a report on Berkeley Lights entitled "Fleecing Customers And IPO Bagholders With A $2 Million Black Box That’s A Clunker." The Scorpion report challenged the Company’s representations regarding its only product, the Beacon, a $2 million laboratory instrument. "

More news about Berkeley Lights.

Most Active Losers Today

1. Daseke (DSKEW) – -26.03%

NASDAQ Composite ended the session with Daseke dropping 26.03% to $0.05 on Friday, after five successive sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Daseke’s last close was $0.05, 26.26% under its 52-week high of $0.07.

Daseke’s Stock Yearly Top and Bottom Value

Daseke’s stock is valued at $0.05 at 16:32 EST, way below its 52-week high of $0.07 and way higher than its 52-week low of $0.04.

More news about Daseke.

2. Brilliant Acquisition Corporation (BRLIW) – -15.26%

NASDAQ Composite ended the session with Brilliant Acquisition Corporation dropping 15.26% to $0.16 on Friday, after five successive sessions in a row of losses. NASDAQ Composite rose 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend trading session today.

Brilliant Acquisition Corporation’s last close was $0.16, 10.56% below its 52-week high of $0.18.

Brilliant Acquisition Corporation’s Stock Yearly Top and Bottom Value

Brilliant Acquisition Corporation’s stock is valued at $0.16 at 16:32 EST, under its 52-week low of $0.16.

More news about Brilliant Acquisition Corporation.

3. CureVac N.V. (CVAC) – -14.1%

NASDAQ Composite ended the session with CureVac N.V. falling 14.1% to $23.22 on Friday, after four successive sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for CureVac N.V. is 1299720 which is 87.58% above its average volume of 692860.

CureVac N.V.’s last close was $27.03, 79.68% below its 52-week high of $133.00.

CureVac N.V.’s Revenue

Year-on-year quarterly revenue growth declined by 11.4%, now sitting on 67.81M for the twelve trailing months.

CureVac N.V.’s Stock Yearly Top and Bottom Value

CureVac N.V.’s stock is valued at $23.22 at 16:32 EST, way below its 52-week high of $133.00 and higher than its 52-week low of $23.09.

CureVac N.V.’s Moving Average

CureVac N.V.’s worth is way under its 50-day moving average of $37.84 and way under its 200-day moving average of $65.03.

More news about CureVac N.V..

4. Avinger (AVGR) – -12.15%

NASDAQ Composite ended the session with Avinger falling 12.15% to $0.31 on Friday while NASDAQ Composite jumped 0.05% to $14,942.83.

Volume

Today’s last reported volume for Avinger is 5898710 which is 190.33% above its average volume of 2031720.

Avinger’s last close was $0.31, 88.25% under its 52-week high of $2.67.

Avinger’s Sales

Avinger’s sales growth is a negative 16.2% for the current quarter and 5.5% for the next. The company’s growth estimates for the current quarter and the next is 14.3% and 14.3%, respectively.

Avinger’s Revenue

Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 10.46M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Avinger’s stock is considered to be overbought (>=80).

Avinger’s Stock Yearly Top and Bottom Value

Avinger’s stock is valued at $0.31 at 16:32 EST, under its 52-week low of $0.31.

Avinger’s Moving Average

Avinger’s value is way below its 50-day moving average of $0.59 and way below its 200-day moving average of $0.89.

More news about Avinger.

5. Black Diamond Therapeutics (BDTX) – -11.76%

NASDAQ Composite ended the session with Black Diamond Therapeutics dropping 11.76% to $4.50 on Friday, following the last session’s downward trend. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Black Diamond Therapeutics is 397171 which is 28.91% below its average volume of 558732.

Black Diamond Therapeutics’s last close was $4.51, 84.79% below its 52-week high of $29.65.

The company’s growth estimates for the current quarter and the next is a negative 60.3% and a negative 22.6%, respectively.

Black Diamond Therapeutics’s Stock Yearly Top and Bottom Value

Black Diamond Therapeutics’s stock is valued at $4.50 at 16:32 EST, way under its 52-week high of $29.65 and higher than its 52-week low of $4.32.

Black Diamond Therapeutics’s Moving Average

Black Diamond Therapeutics’s worth is way under its 50-day moving average of $6.25 and way below its 200-day moving average of $11.94.

More news about Black Diamond Therapeutics.

6. BeyondSpring (BYSI) – -10.59%

NASDAQ Composite ended the session with BeyondSpring sliding 10.59% to $3.80 on Friday, after two successive sessions in a row of losses. NASDAQ Composite jumped 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for BeyondSpring is 1185420 which is 35.76% below its average volume of 1845450.

BeyondSpring’s last close was $3.80, 88.48% below its 52-week high of $33.00.

The company’s growth estimates for the present quarter is 50% and a drop 18.2% for the next.

BeyondSpring’s Stock Yearly Top and Bottom Value

BeyondSpring’s stock is valued at $3.80 at 16:32 EST, way under its 52-week high of $33.00 and higher than its 52-week low of $3.64.

BeyondSpring’s Moving Average

BeyondSpring’s worth is way under its 50-day moving average of $8.38 and way under its 200-day moving average of $12.92.

More news about BeyondSpring.

7. BiondVax Pharmaceuticals Ltd. (BVXV) – -9.45%

NASDAQ Composite ended the session with BiondVax Pharmaceuticals Ltd. falling 9.45% to $1.82 on Friday, after two consecutive sessions in a row of losses. NASDAQ Composite rose 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for BiondVax Pharmaceuticals Ltd. is 647878 which is 80.23% below its average volume of 3277820.

BiondVax Pharmaceuticals Ltd.’s last close was $1.71, 76.32% below its 52-week high of $7.22.

BiondVax Pharmaceuticals Ltd.’s Stock Yearly Top and Bottom Value

BiondVax Pharmaceuticals Ltd.’s stock is valued at $1.82 at 16:32 EST, way under its 52-week high of $7.22 and way higher than its 52-week low of $1.36.

BiondVax Pharmaceuticals Ltd.’s Moving Average

BiondVax Pharmaceuticals Ltd.’s worth is under its 50-day moving average of $2.00 and way under its 200-day moving average of $2.56.

More news about BiondVax Pharmaceuticals Ltd..

8. American Virtual Cloud Technologies (AVCTW) – -9.14%

NASDAQ Composite ended the session with American Virtual Cloud Technologies falling 9.14% to $0.20 on Friday while NASDAQ Composite rose 0.05% to $14,942.83.

American Virtual Cloud Technologies ‘s last close was $0.20, 9.05% below its 52-week high of $0.22.

American Virtual Cloud Technologies ‘s Stock Yearly Top and Bottom Value

American Virtual Cloud Technologies ‘s stock is valued at $0.20 at 16:32 EST, under its 52-week high of $0.22 and above its 52-week low of $0.19.

More news about American Virtual Cloud Technologies .

9. Trip.com (TCOM) – -7.15%

NASDAQ Composite ended the session with Trip.com falling 7.15% to $23.23 on Friday, after two consecutive sessions in a row of losses. NASDAQ Composite rose 0.05% to $14,942.83, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Trip.com is 7840100 which is 34.57% above its average volume of 5825880.

Trip.com’s last close was $24.13, 46.6% below its 52-week high of $45.19.

Trip.com’s Sales

Trip.com’s sales growth is 83% for the current quarter and 38.5% for the next. The company’s growth estimates for the present quarter is 120.7% and a drop 33.3% for the next.

Trip.com’s Revenue

Year-on-year quarterly revenue growth declined by 13.2%, now sitting on 17.69B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Trip.com’s stock is considered to be oversold (<=20).

Trip.com’s Stock Yearly Top and Bottom Value

Trip.com’s stock is valued at $23.23 at 16:32 EST, below its 52-week low of $23.61.

Trip.com’s Moving Average

Trip.com’s worth is way under its 50-day moving average of $29.64 and way under its 200-day moving average of $33.27.

More news about Trip.com.

10. Crexendo (CXDO) – -6.55%

NASDAQ Composite ended the session with Crexendo falling 6.55% to $4.42 on Friday while NASDAQ Composite jumped 0.05% to $14,942.83.

Volume

Today’s last reported volume for Crexendo is 41006 which is 18.84% below its average volume of 50530.

Crexendo’s last close was $4.40, 45.54% under its 52-week high of $8.08.

Crexendo’s Sales

Crexendo’s sales growth is 104% for the ongoing quarter and 105.5% for the next.

Crexendo’s Revenue

Year-on-year quarterly revenue growth grew by 112.6%, now sitting on 23.42M for the twelve trailing months.

Crexendo’s Stock Yearly Top and Bottom Value

Crexendo’s stock is valued at $4.42 at 16:32 EST, way under its 52-week high of $8.08 and above its 52-week low of $4.29.

Crexendo’s Moving Average

Crexendo’s value is way below its 50-day moving average of $5.05 and way under its 200-day moving average of $5.66.

More news about Crexendo.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here